Otsuka (OTSKY) Projected to Announce Earnings on Friday

Key Points

• Otsuka is expected to report earnings after the market closes on Friday, October 30. Analysts forecast $0.59 in earnings per share and $4.42 billion in revenue, while the company’s FY 2026 guidance is $2.119 EPS.
• In its previous quarter, Otsuka reported $0.70 EPS and $4.41 billion in revenue, exceeding consensus estimates of $0.51 EPS and $3.95 billion in revenue.
• Otsuka shares opened at $39.42, near their 52-week high of $40.92. Analyst sentiment is currently “Moderate Buy,” following Zacks Research’s upgrade to “Strong Buy.”

Otsuka (OTCMKTS:OTSKY - Get Free Report) is projected to post its results after the market closes on Friday, October 30th. Analysts expect Otsuka to announce earnings of $0.59 per share and revenue of $4.42 billion for the quarter. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS.

Otsuka (OTCMKTS:OTSKY - Get Free Report) last released its quarterly earnings data on Friday, July 31st. The company reported $0.70 EPS for the quarter, topping analysts' consensus estimates of $0.51 by $0.19. The firm had revenue of $4.41 billion for the quarter, compared to the consensus estimate of $3.95 billion. Otsuka had a net margin of 15.50% and a return on equity of 12.86%. On average, analysts expect Otsuka to post $2.23 EPS for the current fiscal year and $2.35 EPS for the next fiscal year.

Otsuka Stock Up 0.2%

OTSKY opened at $39.42 on Friday. The business's fifty day moving average is $37.28 and its two-hundred day moving average is $35.69. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.65 and a current ratio of 2.21. The company has a market cap of $42.34 billion, a price-to-earnings ratio of 15.81, a PEG ratio of 2.83 and a beta of 0.09. Otsuka has a one year low of $26.11 and a one year high of $40.92.

Analyst Ratings Changes

Separately, Zacks Research upgraded Otsuka from a "hold" rating to a "strong-buy" rating in a report on Friday, October 9th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, Otsuka currently has an average rating of "Moderate Buy".

Otsuka Company Profile

Otsuka Holdings Co, Ltd. is a Japan-based healthcare company that manages a group of businesses focused primarily on pharmaceuticals, nutraceuticals, and consumer health products. Through its subsidiaries, the company researches, develops, manufactures, and markets prescription medicines, over-the-counter products, functional foods, and beverages.

Its pharmaceutical operations address areas including psychiatry, oncology, cardiovascular and renal diseases, and several other specialty conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.